BLUTTEST AUF EGFR-MUTATIONEN

Patent europeic · EP2964781 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2964781
Numer da la dumonda
EP14708273
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
07-03-2014
Publitgà
13-01-2016
Concedì
10-01-2018
La protecziun finescha il pli tard
06-03-2034
Proxima taxa annuala scadenta
31-03-2027
Classas IPC
C12Q 1/68 (2018.01)
Prioritad
US 201361774946 P 08.03.2013
US 201361886619 P 03.10.2013
Dumonda PCT
PCT/EP2014/054409 07.03.2014
Publicaziun PCT
WO2014/135669 12.09.2014
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-04-2026

    Midada

    Published in Swissreg on 01.04.2026

  2. 01-04-2025

    Midada

    Published in Swissreg on 01.04.2025

  3. 01-04-2024

    Midada

    Published in Swissreg on 01.04.2024

  4. 01-04-2023

    Midada

    Published in Swissreg on 01.04.2023

  5. 10-01-2018

    Concedì

    Published in Swissreg on 10.01.2018

Partidas

Possessur

F. Hoffmann-La Roche AG

Grenzacherstrasse 124, 4070 Basel

Inventur

KLUGHAMMER, Barbara

79618 Rheinfelden, DE

MELDGAARD, Peter

DK-8230 Aabyhoj, DK

SORENSEN, Boe

DK-8330 Beder, DK

TSAI, Julie

Newark California 94560, US

WEN, Wei

Santa Clara California 95051, US

WU, Lin

Moraga California 94556, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.